These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 28392201)

  • 21. Number of patients eligible for fast track access to drugs through the cancer drugs fund is slashed.
    Torjesen I
    BMJ; 2013 Apr; 346():f2197. PubMed ID: 23568803
    [No Abstract]   [Full Text] [Related]  

  • 22. The shortage of drugs to treat pediatric malignancies: why does this happen?
    Kline NE
    J Pediatr Oncol Nurs; 2005; 22(6):303-4. PubMed ID: 16216892
    [No Abstract]   [Full Text] [Related]  

  • 23. Health secretary demands patients have equal access to cancer drugs.
    Dyer O
    BMJ; 2003 Nov; 327(7422):1007. PubMed ID: 14593014
    [No Abstract]   [Full Text] [Related]  

  • 24. Patients demanding access to cancer drugs call off hunger strike.
    Siegel-Itzkovich J
    BMJ; 2006 Jun; 332(7554):1352. PubMed ID: 16763238
    [No Abstract]   [Full Text] [Related]  

  • 25. Challenges of accessing cancer medicines in Australia.
    Olver I
    Lancet Oncol; 2013 Oct; 14(11):1040-1042. PubMed ID: 24079861
    [No Abstract]   [Full Text] [Related]  

  • 26. Inequalities in access to renal cancer drugs.
    Fricker J
    Eur J Cancer; 2007 May; 43(8):1226. PubMed ID: 17632887
    [No Abstract]   [Full Text] [Related]  

  • 27. Cancer Care Ontario's New Drug Funding Program: controlled introduction of expensive anticancer drugs.
    Evans WK; Nefsky M; Pater J; Browman G; Cowan DH
    Chronic Dis Can; 2002; 23(4):152-6. PubMed ID: 12517323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Obama authorizes FDA to address drug shortage.
    Stone A
    ONS Connect; 2012 Jan; 27(1):18. PubMed ID: 22355896
    [No Abstract]   [Full Text] [Related]  

  • 29. Accelerated access to new drugs and technologies.
    Naci H; Mossialos E
    BMJ; 2017 Nov; 359():j5387. PubMed ID: 29167095
    [No Abstract]   [Full Text] [Related]  

  • 30. Children's clinical cancer trials: what needs to change to allow children access to new cancer drugs?
    Moreno L; Pearson AD
    Expert Rev Clin Pharmacol; 2015; 8(6):665-7. PubMed ID: 26307367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The shortage of essential chemotherapy drugs in the United States.
    Gatesman ML; Smith TJ
    N Engl J Med; 2011 Nov; 365(18):1653-5. PubMed ID: 22040130
    [No Abstract]   [Full Text] [Related]  

  • 32. [Access to cancer medications. Quebec is behind schedule].
    Couillard K
    Perspect Infirm; 2016; 13(1):21-2. PubMed ID: 26998542
    [No Abstract]   [Full Text] [Related]  

  • 33. Access to cancer drugs: local autonomy or local tyranny?
    Waxman J
    Br J Hosp Med (Lond); 2008 Aug; 69(8):436-7. PubMed ID: 18783089
    [No Abstract]   [Full Text] [Related]  

  • 34. Cancer and palliative care in Africa.
    Kimani KN; Namukwaya E; Grant L; Murray SA
    Eur J Cancer Care (Engl); 2017 Jan; 26(1):. PubMed ID: 28111855
    [No Abstract]   [Full Text] [Related]  

  • 35. Access to cancer drugs: local autonomy or local tyranny?
    Sikora K
    Br J Hosp Med (Lond); 2008 Sep; 69(9):537; author reply 537. PubMed ID: 18819312
    [No Abstract]   [Full Text] [Related]  

  • 36. Access to cancer drugs: local autonomy or local tyranny?
    Dillon A
    Br J Hosp Med (Lond); 2008 Sep; 69(9):537; author reply 537. PubMed ID: 18822467
    [No Abstract]   [Full Text] [Related]  

  • 37. Ethical challenges: managing oncology drug shortages.
    Valgus J; Singer EA; Berry SR; Rathmell WK
    J Oncol Pract; 2013 Mar; 9(2):e21-3. PubMed ID: 23814521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ensuring Access to Injectable Generic Drugs - The Case of Intravesical BCG for Bladder Cancer.
    Davies BJ; Hwang TJ; Kesselheim AS
    N Engl J Med; 2017 Apr; 376(15):1401-1403. PubMed ID: 28402764
    [No Abstract]   [Full Text] [Related]  

  • 39. All children have a right to full access to treatment for cancer.
    Eden T; Pui CH; Schrappe M; Tognoni G; Masera G; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
    Lancet; 2004 Sep 25-Oct 1; 364(9440):1121-2. PubMed ID: 15451211
    [No Abstract]   [Full Text] [Related]  

  • 40. Targeted immunotherapies overtaking emerging oncology market value based growth.
    Jakovljevic MB
    J BUON; 2015; 20(1):350-1. PubMed ID: 25778340
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.